CNR1 Antikörper (Internal Region)

Produktnummer ABIN374611

Dieses Ziege Polyklonal-Antikörper erkennt spezifisch CNR1 in WB. Er zeigt eine Reaktivität gegenüber Human, Ratte, Maus, Hund und Cat.

Kurzübersicht für CNR1 Antikörper (Internal Region) (ABIN374611)

Target: CNR1 (Cannabinoid Receptor 1 (CNR1))

Reaktivität: Human, Ratte, Maus, Hund, Cat

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser CNR1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-CNR1 Antikörper

Bindungsspezifität: Internal Region

Spezifität: This antibody reacts to Cannabinoid receptor 1.

Kreuzreaktivität (Details): Species reactivity (expected):Rat, Canine.
Species reactivity (tested):Human, Mouse.

Aufreinigung: Affinity chromatography

Immunogen: Peptide with sequence C-HTSEDGKVQVTRPDQ, from the internal region of the protein sequence

Anwendungsinformationen

Applikationshinweise: Peptide ELISA: 1/32000. Western Blot: 0.1 - 0.3 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0,5 mg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu CNR1

Target: CNR1 (Cannabinoid Receptor 1 (CNR1))

Andere Bezeichnung: Cannabinoid Receptor 1

Hintergrund: Cannabinoid Receptor 1 is one of two main cannabinoid receptors which are G-protein-coupled receptors inhibiting adenylate cyclase activity. The CB(1) receptor is densely distributed in areas of the brain related to motor control, cognition, emotional responses, motivated behaviour and homeostasis. Cannabinoid receptors have a complex molecular architecture that allows a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects. Recent pharmacological advances have led to the synthesis of cannabinoid receptor agonists and antagonists. This has helped in the development of new strategies for the treatment of pain, obesity, neurological diseases including multiple sclerosis, emotional disturbances such as anxiety and other psychiatric disorders including drug and alcohol addiction.Synonyms: CANN6, CB-R, CB1, CNR, CNR1

Gen-ID: 1268, 9606

UniProt: P21554

Pathways: Feeding Behaviour